Benzbromarone 200 mg | 99.94%
TargetMol
Benzbromarone
Search Results
3,5-O-Dicaffeoylquinic acid 1 mg | 99.72%
TargetMol
3,5-Dicaffeoylquinic acid is an isolated compound from Artemisia argyi; its ester derivatives exert anti-leucyl-tRNA synthetase of Giardia lamblia (GlLeuRS) and potential anti-giardial effects. 3,5-di-O-caffeoylquinic acid as a neuraminidase inhibitory ligand in Flos Lonicerae, it has neuroprotective effects on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1. 3,5-di-O-caffeoylquinic acid also has antioxidant […]
More Information Supplier Page3,5-O-Dicaffeoylquinic acid
ZM241385 25 mg | 95.28%
TargetMol
ZM-241385 is a high-affinity antagonist ligand selective for the adenosine A2A receptor.
More Information Supplier PageZM241385
ZM241385 100 mg | 95.28%
TargetMol
ZM-241385 is a high-affinity antagonist ligand selective for the adenosine A2A receptor.
More Information Supplier PageZM241385
Mebhydrolin 100 mg | 99.73%
TargetMol
Mebhydrolin
Mebhydrolin 200 mg | 99.73%
TargetMol
Mebhydrolin
Mebhydrolin 500 mg | 99.73%
TargetMol
Mebhydrolin
Ibrutinib 100 mg | 99.79%
TargetMol
Ibrutinib is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.
More Information Supplier PageIbrutinib
Ibrutinib 200 mg | 99.79%
TargetMol
Ibrutinib is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.
More Information Supplier PageIbrutinib
Ibrutinib 50 mg | 99.79%
TargetMol
Ibrutinib is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.
More Information Supplier PageIbrutinib